FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079580065> ?p ?o ?g. }

• W2079580065 endingPage "e231" @default.
• W2079580065 startingPage "e225" @default.
• W2079580065 abstract "Introduction Diabetes is a prothrombotic state involving a more thrombogenic fibrin network. In the present study we investigated the effects of lipid-lowering therapy with atorvastatin on fibrin network structure and platelet-derived microparticles in patients with type 1 diabetes and dyslipidemia. Materials and Methods Twenty patients were treated with atorvastatin (80 mg daily) or placebo during 2 months in a randomized, double-blind, cross-over study. Fibrin network permeability, expression of glycoprotein IIIa, P-selectin and tissue factor on platelet-derived microparticles, plasma endogenous thrombin potential, plasminogen activator inhibitor-1 and tissue plasminogen activator antigen levels were assessed. Additionally, levels of plasma fibrinogen, high-sensitivity C-reactive protein and glycated haemoglobin were measured. Results During treatment with atorvastatin, fibrin network permeability increased (p=0.01), while endogenous thrombin potential and expression of glycoprotein IIIa, P-selectin and tissue factor decreased (p<0.01). In vitro experiments indicated that platelet-derived microparticles influence the fibrin network formation as fibrin network permeability decreased significantly when platelet-derived microparticles were added to normal plasma. Baseline levels of plasminogen activator inhibitor-1 and tissue plasminogen activator antigen as well as plasma fibrinogen and high-sensitivity C-reactive protein were within reference values and not significantly changed during atorvastatin treatment, while glycated haemoglobin increased 0.3% (p<0.001). Conclusions Novel treatment effects were found in patients with type 1 diabetes and dyslipidemia during atorvastatin therapy, i.e. a more porous fibrin network, to which reduced expression of glycoprotein IIIa, P-selectin and tissue factor on platelet-derived microparticles may contribute. The observed impairment of glycemic control during long-term statin treatment deserves attention." @default.
• W2079580065 created "2016-06-24" @default.
• W2079580065 creator A5007308043 @default.
• W2079580065 creator A5007770680 @default.
• W2079580065 creator A5023390914 @default.
• W2079580065 creator A5026021008 @default.
• W2079580065 creator A5031846880 @default.
• W2079580065 creator A5049200752 @default.
• W2079580065 creator A5056673483 @default.
• W2079580065 creator A5061424607 @default.
• W2079580065 creator A5085007309 @default.
• W2079580065 date "2010-09-01" @default.
• W2079580065 modified "2023-10-18" @default.
• W2079580065 title "Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia" @default.
• W2079580065 cites W1593008417 @default.
• W2079580065 cites W1893775 @default.
• W2079580065 cites W1970249515 @default.
• W2079580065 cites W1971163980 @default.
• W2079580065 cites W1984353324 @default.
• W2079580065 cites W1997674067 @default.
• W2079580065 cites W2008890523 @default.
• W2079580065 cites W2012330678 @default.
• W2079580065 cites W2012818276 @default.
• W2079580065 cites W2013737297 @default.
• W2079580065 cites W2021942472 @default.
• W2079580065 cites W2039401099 @default.
• W2079580065 cites W2043932794 @default.
• W2079580065 cites W2044452035 @default.
• W2079580065 cites W2056480338 @default.
• W2079580065 cites W2057007282 @default.
• W2079580065 cites W2058372581 @default.
• W2079580065 cites W2059715254 @default.
• W2079580065 cites W2068898353 @default.
• W2079580065 cites W2072299517 @default.
• W2079580065 cites W2072654937 @default.
• W2079580065 cites W2075259073 @default.
• W2079580065 cites W2081143213 @default.
• W2079580065 cites W2084688613 @default.
• W2079580065 cites W2090475686 @default.
• W2079580065 cites W2095345326 @default.
• W2079580065 cites W2107295258 @default.
• W2079580065 cites W2107383916 @default.
• W2079580065 cites W2114435292 @default.
• W2079580065 cites W2125487451 @default.
• W2079580065 cites W2129464080 @default.
• W2079580065 cites W2134627002 @default.
• W2079580065 cites W2137983259 @default.
• W2079580065 cites W2144537409 @default.
• W2079580065 cites W2149220775 @default.
• W2079580065 cites W2395107521 @default.
• W2079580065 cites W4250054871 @default.
• W2079580065 doi "https://doi.org/10.1016/j.thromres.2010.05.023" @default.
• W2079580065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20637495" @default.
• W2079580065 hasPublicationYear "2010" @default.
• W2079580065 type Work @default.
• W2079580065 sameAs 2079580065 @default.
• W2079580065 citedByCount "58" @default.
• W2079580065 countsByYear W20795800652012 @default.
• W2079580065 countsByYear W20795800652013 @default.
• W2079580065 countsByYear W20795800652014 @default.
• W2079580065 countsByYear W20795800652015 @default.
• W2079580065 countsByYear W20795800652016 @default.
• W2079580065 countsByYear W20795800652017 @default.
• W2079580065 countsByYear W20795800652018 @default.
• W2079580065 countsByYear W20795800652019 @default.
• W2079580065 countsByYear W20795800652020 @default.
• W2079580065 countsByYear W20795800652021 @default.
• W2079580065 countsByYear W20795800652022 @default.
• W2079580065 countsByYear W20795800652023 @default.
• W2079580065 crossrefType "journal-article" @default.
• W2079580065 hasAuthorship W2079580065A5007308043 @default.
• W2079580065 hasAuthorship W2079580065A5007770680 @default.
• W2079580065 hasAuthorship W2079580065A5023390914 @default.
• W2079580065 hasAuthorship W2079580065A5026021008 @default.
• W2079580065 hasAuthorship W2079580065A5031846880 @default.
• W2079580065 hasAuthorship W2079580065A5049200752 @default.
• W2079580065 hasAuthorship W2079580065A5056673483 @default.
• W2079580065 hasAuthorship W2079580065A5061424607 @default.
• W2079580065 hasAuthorship W2079580065A5085007309 @default.
• W2079580065 hasConcept C126322002 @default.
• W2079580065 hasConcept C134018914 @default.
• W2079580065 hasConcept C185592680 @default.
• W2079580065 hasConcept C186738567 @default.
• W2079580065 hasConcept C203014093 @default.
• W2079580065 hasConcept C2776572282 @default.
• W2079580065 hasConcept C2777482532 @default.
• W2079580065 hasConcept C2778382381 @default.
• W2079580065 hasConcept C2779036427 @default.
• W2079580065 hasConcept C2779679481 @default.
• W2079580065 hasConcept C54173615 @default.
• W2079580065 hasConcept C71924100 @default.
• W2079580065 hasConcept C89560881 @default.
• W2079580065 hasConcept C98274493 @default.
• W2079580065 hasConceptScore W2079580065C126322002 @default.
• W2079580065 hasConceptScore W2079580065C134018914 @default.
• W2079580065 hasConceptScore W2079580065C185592680 @default.
• W2079580065 hasConceptScore W2079580065C186738567 @default.
• W2079580065 hasConceptScore W2079580065C203014093 @default.

• next